Snapshot: March Highlights

A selection of articles you may have missed from March 2023, including discussion of the benefits and risks of both CAR-T and NK cell therapies, insights into how companies can source financing when VC cash is scarce, and a highlight on Pfizer's mammoth purchase of Seagen.  

March Snapshot
• Source: Alamy

More from Business Strategy

More from In Vivo